Physician profile
Michael Pan
NPI 1649831553
$5,698.26
in general payments reported to CMS, 2019-2025
26 companies · $3,218 in 2025
The $3,218 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $84.05 · 2023: $1,232 · 2024: $1,164 · 2025: $3,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,955 · Travel and Lodging: $1,287 · Education: $161 · Grant: $125 · Gift: $86.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,954.52 |
| Travel and Lodging | $1,286.94 |
| Education | $161.10 |
| Grant | $125.00 |
| Gift | $86.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,560.70 | 2023-2025 | Farapulse, Resonate El Icd Vr, Rhythmia Mapping System |
| Medtronic, INC. | $456.30 | 2022-2025 | Micra, Affera Mapping System, Pulseselect |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $279.50 | 2023-2025 | Lifevest |
| Abiomed | $271.10 | 2023-2025 | Impella |
| Amgen INC. | $267.24 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $247.64 | 2023-2024 | Camzyos |
| Pfizer INC. | $226.04 | 2023-2024 | |
| Inari Medical, INC. | $214.13 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Scpharmaceuticals INC. | $195.71 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $138.32 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $120.26 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $102.77 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.34 | 2022-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $88.18 | 2023-2024 | Xarelto |
| Biosense Webster, INC. | $73.88 | 2025 | Carto 3 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $69.24 | 2023-2025 | Andexxa, Farxiga, Wainua |
| Kiniksa Pharmaceuticals International, Plc | $49.29 | 2024 | Arcalyst |
| Acist Medical Systems, INC. | $36.03 | 2025 | |
| Terumo Medical Corporation | $35.82 | 2023 | Glidewire |
| Bayer Healthcare Pharmaceuticals INC. | $31.63 | 2025 | |
| Altathera Pharmaceuticals LLC | $27.60 | 2024 | Sotalol Hydrochloride |
| Edwards Lifesciences Corporation | $24.70 | 2023 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $23.27 | 2024 | Winrevair |
| Abbott Laboratories | $22.39 | 2025 | Ensite |
| Philips North America LLC | $20.25 | 2023 | |
| Asahi Intecc USA, INC. | $19.93 | 2024 | Peripheral Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.